Press Releases

Data demonstrates 60 percent of wounds achieved complete wound closure, which is compatible with the healing rates observed in previous NEOX Cord 1K retrospective studies. Miami, FL – October 10, 2019 – Miami, FL – October 10, 2019 – Amniox® Medical, Inc. (Amniox), a TissueTechTM, Inc. company and leader in the clinical application of amniotic […]

Human Birth Tissue Manufacturer is Scaling Up to Transition into a Biologics Provider Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In […]

Human Birth Tissue Manufacturer Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President […]

Organization Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 11, 2019 – Bio-Tissue®, Inc., a TissueTech,TM Inc. company, and pioneer and market leader in the development and clinical application of Cryopreserved Amniotic Membrane (CAM) products for ocular surface disease and injury, today announced the expansion […]

Manufacturer of Human Birth Tissue Products Ramps Up Workflow Processes as it Transitions into a Biologics Provider Miami, FL – September 5, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Sherry Saurini to the position of Vice President of Quality […]

Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation Unified platform creates a single source of truth for all data, enabling teams to focus on critical oversight activities, site satisfaction and improved patient experiences Miami, Fla. – July 3, 2019 – Medidata announced that TissueTech, Inc.. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform […]

Miami, Fla. – June 26, 2019 – TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbilical cord and amniotic membrane, today announced the closing of an $82.25 million round of Preferred C equity financing led by EW Healthcare Partners (formerly Essex Woodlands) and followed by the third round of continuous investments from Ballast Point […]

Miami, Fla. – May 2, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and the market leader in the clinical application of cryopreserved amniotic membrane-based products for the treatment of diseases and disorders of the ocular surface, today announced that Mark S. Milner, M.D., FACS, Associate Clinical Professor at Yale University Medical School and Co-founder […]

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]